Mojtaba Tabandeh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Mojtaba Tabandeh has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
Rusnah Syahila Duali Hussen
Chemistry Department, Faculty of Science, University of Malaya, 50603, Kuala Lumpur, Malaysia
4 shared publications- Thorsten Heidelberg
Faculty of Science, Chemistry Department Universiti Malaya Kuala Lumpur Malaysia
4 shared publications Abbas Abdulameer Salman
Chemistry Department, Faculty of Science, University of Malaya, 50603, Kuala Lumpur, Malaysia; College of Pathological Analysis Technology, Al-Bayan University, Bhagdad, Iraq
3 shared publicationsEan Wai Goh
Chemistry Department, Faculty of Science, University of Malaya, 50603, Kuala Lumpur, Malaysia
2 shared publications- Lifang Zhang
Osteoimmunology & Drug Discovery Research Group, Department of Biology, College of Science, Mathematics and Technology, Wenzhou-Kean University, 88 Daxue Road, Wenzhou 325060, China
2 shared publications - Vishwa Deepak
Osteoimmunology & Drug Discovery Research Group, Department of Biology, College of Science, Mathematics and Technology, Wenzhou-Kean University, 88 Daxue Road, Wenzhou 325060, China
2 shared publications
Latest Publications
- Open Access
- 11 August 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (16) , 7159
Asarinin Inhibits RANKL-Induced Osteoclast Differentiation by Targeting the p38/ERK–c-Fos–NFATc1 Axis
Excessive osteoclast formation is a key contributor to pathological bone loss in disorders such as osteoporosis and rheumatoid arthritis. Asarinin, a natural lignan, has not previously been examined in the context of osteoclast differentiation. Here, we investigated the anti-osteoclastogenic effects of asarinin using RANKL-stimulated RAW264.7 cells. Asarinin significantly suppressed TRAP-positive multinucleated osteoclast formation. Mechanistically, asarinin selectively inhibited RANKL-induced phosphorylation of p38 and ERK MAPKs, leading to reduced c-Fos expression and inhibition of NFATc1 activation. In addition, asarinin disrupted actin ring formation in mature osteoclasts. Collectively, these findings identify asarinin as a pathway-selective inhibitor of osteoclast differentiation, acting through a mechanism consistent with modulation of the p38/ERK–c-Fos–NFATc1 signaling cascade while sparing parallel signaling pathways.
- 11 August 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (16) , 7159
Open AccessAsarinin Inhibits RANKL-Induced Osteoclast Differentiation by Targeting the p38/ERK–c-Fos–NFATc1 Axis
Excessive osteoclast formation is a key contributor to pathological bone loss in disorders such as osteoporosis and rheumatoid arthritis. Asarinin, a natural lignan, has not previously been examined in the context of osteoclast differentiation. Here, we investigated the anti-osteoclastogenic effects of asarinin using RANKL-stimulated RAW264.7 cells. Asarinin significantly suppressed TRAP-positive multinucleated osteoclast formation. Mechanistically, asarinin selectively inhibited RANKL-induced phosphorylation of p38 and ERK MAPKs, leading to reduced c-Fos expression and inhibition of NFATc1 activation. In addition, asarinin disrupted actin ring formation in mature osteoclasts. Collectively, these findings identify asarinin as a pathway-selective inhibitor of osteoclast differentiation, acting through a mechanism consistent with modulation of the p38/ERK–c-Fos–NFATc1 signaling cascade while sparing parallel signaling pathways.
- Open Access
- 17 April 2026
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 48 (4) , 412
Angelic Acid Prevents RANKL-Induced Osteoclastogenesis Through Pathway-Biased Inhibition of MAPK–NFATc1 Signaling
Excessive osteoclast activity drives inflammatory bone loss in osteoporosis, rheumatoid arthritis, and periodontitis. Natural compounds represent promising therapeutic candidates with favorable safety profiles; however, few exhibit pathway-biased mechanisms of action. Here, we report that angelic acid (AA), a naturally occurring unsaturated monocarboxylic acid, potently inhibits RANKL-induced osteoclastogenesis. This effect occurs with an IC50 of 1.9 µM without cytotoxicity. Mechanistically, AA selectively suppressed RANKL-activated phosphorylation of ERK1/2, p38, and JNK (all three MAPK branches), while leaving NF-κB transcriptional activity unaffected. This preferential MAPK suppression disrupted downstream NFATc1 nuclear translocation, thereby preventing NFATc1-driven transcription of osteoclast-specific effector genes including TRAP, cathepsin K, and Atp6v0d2. These findings identify AA as a novel inhibitor of the RANKL–MAPK–NFATc1 axis, providing a mechanistic foundation for its therapeutic development in osteoporosis and other osteolytic diseases.
- 17 April 2026
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 48 (4) , 412
Open AccessAngelic Acid Prevents RANKL-Induced Osteoclastogenesis Through Pathway-Biased Inhibition of MAPK–NFATc1 Signaling
Excessive osteoclast activity drives inflammatory bone loss in osteoporosis, rheumatoid arthritis, and periodontitis. Natural compounds represent promising therapeutic candidates with favorable safety profiles; however, few exhibit pathway-biased mechanisms of action. Here, we report that angelic acid (AA), a naturally occurring unsaturated monocarboxylic acid, potently inhibits RANKL-induced osteoclastogenesis. This effect occurs with an IC50 of 1.9 µM without cytotoxicity. Mechanistically, AA selectively suppressed RANKL-activated phosphorylation of ERK1/2, p38, and JNK (all three MAPK branches), while leaving NF-κB transcriptional activity unaffected. This preferential MAPK suppression disrupted downstream NFATc1 nuclear translocation, thereby preventing NFATc1-driven transcription of osteoclast-specific effector genes including TRAP, cathepsin K, and Atp6v0d2. These findings identify AA as a novel inhibitor of the RANKL–MAPK–NFATc1 axis, providing a mechanistic foundation for its therapeutic development in osteoporosis and other osteolytic diseases.
- 1 May 2022
- Published by Elsevier in Molecular Catalysis
- Vol. 523
Recent advancement in deoxygenation of fatty acids via homogeneous catalysis for biofuel production
- 1 May 2022
- Published by Elsevier in Molecular Catalysis
- Vol. 523
Recent advancement in deoxygenation of fatty acids via homogeneous catalysis for biofuel production
- 1 November 2018
- Published by Elsevier in Carbohydrate Research
- Vol. 469, 14-22
Functionalized glycolipids for potential bioconjugation of vesicles
- 1 November 2018
- Published by Elsevier in Carbohydrate Research
- Vol. 469, 14-22
Functionalized glycolipids for potential bioconjugation of vesicles
- 1 May 2018
- Published by Elsevier in Chemistry and Physics of Lipids
- Vol. 212, 111-119
Renewable resources-based approach to biantennary glycolipids
- 1 May 2018
- Published by Elsevier in Chemistry and Physics of Lipids
- Vol. 212, 111-119
Renewable resources-based approach to biantennary glycolipids
- 30 October 2017
- Published by Wiley in Greenhouse Gases: Science and Technology
- Vol. 8 (2) , 324-334
Modification of polyethylene glycol with choline chloride and evaluation of the CO2 absorption capacity of their aqueous solutions
In this study, two new water‐soluble poly ionic liquids (PILs) polyethylene glycol‐ Di choline chloride (PEG‐(ChCl)2) were modified, with two molecular weights of PEG, 400 and 600, to be used as solvents for CO2 capture. The modified polymers were characterized using Fourier transform infra‐red (FT‐IR) spectroscopy and proton nuclear magnetic resonance (1H‐NMR). CO2 absorption using the PILs was conducted at temperatures from 30 to 70°C and at pressures ranging from 10 to 13 bars. Both PILs saturated and then regenerated under the regeneration temperature: 90–100°C. The results showed that most of CO2 in the liquid phase is released through the thermal regeneration before solutions start to boil after three cycles. PEG (400)–(ChCl)2, and PEG(600)–(ChCl)2 with a concentration of 0.03M showed CO2 loading of 16.24 and 15.68, respectively. These results were 25% higher than the original PEG (400–600). © 2017 Society of Chemical Industry and John Wiley & Sons, Ltd.
- 30 October 2017
- Published by Wiley in Greenhouse Gases: Science and Technology
- Vol. 8 (2) , 324-334
Modification of polyethylene glycol with choline chloride and evaluation of the CO2 absorption capacity of their aqueous solutions
In this study, two new water‐soluble poly ionic liquids (PILs) polyethylene glycol‐ Di choline chloride (PEG‐(ChCl)2) were modified, with two molecular weights of PEG, 400 and 600, to be used as solvents for CO2 capture. The modified polymers were characterized using Fourier transform infra‐red (FT‐IR) spectroscopy and proton nuclear magnetic resonance (1H‐NMR). CO2 absorption using the PILs was conducted at temperatures from 30 to 70°C and at pressures ranging from 10 to 13 bars. Both PILs saturated and then regenerated under the regeneration temperature: 90–100°C. The results showed that most of CO2 in the liquid phase is released through the thermal regeneration before solutions start to boil after three cycles. PEG (400)–(ChCl)2, and PEG(600)–(ChCl)2 with a concentration of 0.03M showed CO2 loading of 16.24 and 15.68, respectively. These results were 25% higher than the original PEG (400–600). © 2017 Society of Chemical Industry and John Wiley & Sons, Ltd.
- 1 August 2015
- Published by Elsevier in Carbohydrate Research
- Vol. 412, 28-33
Alkyl-imidazolium glycosides: non-ionic—cationic hybrid surfactants from renewable resources
- 1 August 2015
- Published by Elsevier in Carbohydrate Research
- Vol. 412, 28-33
Alkyl-imidazolium glycosides: non-ionic—cationic hybrid surfactants from renewable resources
- 1 April 2015
- Published by Elsevier in Carbohydrate Research
- Vol. 406, 41-45
Functional glycolipid-crown-ethers by click chemistry
- 1 April 2015
- Published by Elsevier in Carbohydrate Research
- Vol. 406, 41-45
Functional glycolipid-crown-ethers by click chemistry